Louisiana Sues FDA To Keep Abortion Drugs From Being Mailed Into State

Photo: Natalie Behring / Getty Images News / Getty Images

Louisiana is suing the U.S. Food and Drug Administration, asking it to rescind a 2023 rule that allows abortion drugs to be mailed into the state.

During the pandemic, the FDA allowed mifepristone be dispensed without an in-person doctor visit. The lawsuit filed on Monday in Lafayette claims the FDA let the COVID-era rule continue after the emergency was over.

State Attorney General Liz Murrill says the FDA is trying to undermine the Dobbs decision that voided Roe vs. Wade by allowing mifepristone to be mailed into pro-life states.